Davis Hedbany

Davis Hedbany

Auto-generated profile, based on publicly available information

Davis Hedbany

SUNY Upstate Medical University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

5 January 2025 in Foot and Ankle Surgery
Verified
Journal Article
Closed access
NMNathaniel P. Mercer
Nathaniel P. Mercer
BLBradley A Lezak
Bradley A Lezak
DHDavis Hedbany
Davis Hedbany
JBJames J. Butler
James J. Butler
SKSebastian Krebsbach
Sebastian Krebsbach
JKJohn G. Kennedy
John G. Kennedy

1 March 2025 in Journal of Hand and Microsurgery
Verified
Journal Article
Closed access
TMTaylor Manes
Taylor Manes
DHDavis Hedbany
Davis Hedbany
HPHursch Patel
Hursch Patel
SOSylvester Okoro
Sylvester Okoro
MAMichael Anderson
Michael Anderson
BBBryan G. Beutel
Bryan G. Beutel

16 August 2026 in Montefiore Einstein Journal of Musculoskeletal Medicine and Surgery
Verified
Journal Article
Open access
DHDavis Hedbany
Davis Hedbany
VKVictor Koltenyuk
Victor Koltenyuk
MMMatthew Merckling
Matthew Merckling
EPEthan Parisier
Ethan Parisier
OOOserekpamen Omobhude
Oserekpamen Omobhude
MKMatthew Konigsberg
Matthew Konigsberg
Background and Objective: With an aging United States population, the incidence of perioperative complications following orthopedic procedures, including surgical management of olecranon fractures, is increasing. These complications affect not only patient outcomes but also discharge disposition. Identifying risk factors for non-routine hospital discharge, including frailty, is critical for optimizing postoperative care and discharge planning in the elderly. We hypothesized that increasing frailty as measured by the modified five-factor frailty index (mFI-5) would be independently associated with non-routine discharge following surgical fixation of olecranon fractures. Materials and Methods: The National Inpatient Sample (NIS) was analyzed (2015-2019), focusing on elderly patients (aged ≥ 65 years) with displaced olecranon fractures who underwent surgical fixation. Patients were categorized by frailty status using the modified five-factor frailty index (mFI-5). Adverse hospitalization events and discharge status were compared. Results: A total of 5185 patients undergoing surgical intervention for displaced olecranon fractures were included in the study. As rated by the mFI-5, 1125 (21.7%) were non-frail, 2565 (49.5%) were prefrail, 1175 (22.7%) were frail, and 320 (6.2%) were severely frail. Age greater than 80 years was an independent risk factor for non-routine discharge [OR: 2.989 (2.640-3.386), P < 0.001]. Prefrail, frail, and severely frail patients had a significantly increased likelihood of non-routine discharge [OR: 1.422, P < 0.001; OR: 1.857, P < 0.001; and OR: 1.478, P = 0.010, respectively]. Female sex was also an independent predictor [OR: 1.340 (1.158-1.551), P < 0.001]. Conclusion: Frailty, age, and female sex are significant predictors of non-routine discharge in elderly inpatients undergoing surgical fixation for displaced olecranon fractures. These findings highlight the importance of incorporating frailty assessments into both preoperative surgical decision-making and postoperative discharge planning to improve care transitions and outcomes.

4 April 2025 in Journal of Orthopaedic Experience & Innovation
Verified
Journal Article
Open access
PDF file
DHDavis T. Hedbany
Davis T. Hedbany
MSMichael Sacco
Michael Sacco
SMSukrita Menon
Sukrita Menon
HSHarlan Stock
Harlan Stock
JAJames Aglio
James Aglio
TDTimothy A. Damron
Timothy A. Damron
Background: Benign bone tumors are frequently managed by curettage and grafting with autograft, allograft, or synthetic fillers. This study aims to evaluate the safety, efficacy, and radiographic incorporation of CERAMENT, a ceramic bone graft substitute (BGS), in patients following resection of benign bone lesions. Methods: This retrospective chart review included 78 patients treated by the senior author between 2017 and 2023 for benign bone tumors utilizing curettage and BGS. Pre-operative imaging was used to determine the location, type, and size of each lesion, while operative notes documented the defect measurements and the amount of bone filler used. Post-operative radiographs and notes were used to assess complications and monitor graft incorporation, resorption, and bone regeneration. Results: Patients were followed for an average of 12.7 months, during which five lesion recurrences were observed, with three requiring reoperation. One patient experienced a post-surgical pathological fracture. No fractures occurred during the early healing phase of the graft material in the absence of recurrence of the underlying bone tumor. Partial but progressive graft resorption and incorporation with bone healing was evident at 3-months. By 3 months, 88% of patients achieved full weight-bearing status. Advanced or complete graft resorption and incorporation was identified in 72.5% (37/51) of patients at 6-months, 80.6% (28/36) at 1-year, and 84.0% (21/25) at 2-years. Puddling of the BGS was noted in 27.4% of patients at 6-weeks (20/73), persisting in 12% of patients (3/25) at 2-years. The pattern of incorporation was commonly centripetal through a zone of peripheral radiolucency. Radiographic evidence of filler in soft tissue was noted early but resolved over time without clinical manifestation. Conclusion: These findings support CERAMENT as a safe and effective option with a desirable profile of paced bone resorption and incorporation, leading to bone healing in benign bone tumors.